534 related articles for article (PubMed ID: 24503539)
1. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer.
Chen Y; Fu LL; Wen X; Wang XY; Liu J; Cheng Y; Huang J
Cell Death Dis; 2014 Feb; 5(2):e1047. PubMed ID: 24503539
[TBL] [Abstract][Full Text] [Related]
2. Context-dependent role of SIRT3 in cancer.
Zhang J; Ye J; Zhu S; Han B; Liu B
Trends Pharmacol Sci; 2024 Feb; 45(2):173-190. PubMed ID: 38242748
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target.
Zhang J; Xiang H; Liu J; Chen Y; He RR; Liu B
Theranostics; 2020; 10(18):8315-8342. PubMed ID: 32724473
[TBL] [Abstract][Full Text] [Related]
4. CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance.
Liu R; Fan M; Candas D; Qin L; Zhang X; Eldridge A; Zou JX; Zhang T; Juma S; Jin C; Li RF; Perks J; Sun LQ; Vaughan AT; Hai CX; Gius DR; Li JJ
Mol Cancer Ther; 2015 Sep; 14(9):2090-102. PubMed ID: 26141949
[TBL] [Abstract][Full Text] [Related]
5. Advances in characterization of SIRT3 deacetylation targets in mitochondrial function.
Wang S; Zhang J; Deng X; Zhao Y; Xu K
Biochimie; 2020 Dec; 179():1-13. PubMed ID: 32898647
[TBL] [Abstract][Full Text] [Related]
6. Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells.
Zhang L; Ren X; Cheng Y; Huber-Keener K; Liu X; Zhang Y; Yuan YS; Yang JW; Liu CG; Yang JM
Biochem Pharmacol; 2013 Sep; 86(6):726-33. PubMed ID: 23856293
[TBL] [Abstract][Full Text] [Related]
7. Constitutive Activation of NAD-Dependent Sirtuin 3 Plays an Important Role in Tumorigenesis of Chromium(VI)-Transformed Cells.
Clementino M; Kim D; Zhang Z
Toxicol Sci; 2019 May; 169(1):224-234. PubMed ID: 30715550
[TBL] [Abstract][Full Text] [Related]
8. Regulation of mitochondrial F(o)F(1)ATPase activity by Sirt3-catalyzed deacetylation and its deficiency in human cells harboring 4977bp deletion of mitochondrial DNA.
Wu YT; Lee HC; Liao CC; Wei YH
Biochim Biophys Acta; 2013 Jan; 1832(1):216-27. PubMed ID: 23046812
[TBL] [Abstract][Full Text] [Related]
9. Obesity and aging diminish sirtuin 1 (SIRT1)-mediated deacetylation of SIRT3, leading to hyperacetylation and decreased activity and stability of SIRT3.
Kwon S; Seok S; Yau P; Li X; Kemper B; Kemper JK
J Biol Chem; 2017 Oct; 292(42):17312-17323. PubMed ID: 28808064
[TBL] [Abstract][Full Text] [Related]
10. Sirt3 is a tumor suppressor in lung adenocarcinoma cells.
Xiao K; Jiang J; Wang W; Cao S; Zhu L; Zeng H; Ouyang R; Zhou R; Chen P
Oncol Rep; 2013 Sep; 30(3):1323-8. PubMed ID: 23842789
[TBL] [Abstract][Full Text] [Related]
11. The yin and yang faces of the mitochondrial deacetylase sirtuin 3 in age-related disorders.
Gomes P; Viana SD; Nunes S; Rolo AP; Palmeira CM; Reis F
Ageing Res Rev; 2020 Jan; 57():100983. PubMed ID: 31740222
[TBL] [Abstract][Full Text] [Related]
12. Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson's disease.
Shen Y; Wu Q; Shi J; Zhou S
Biomed Pharmacother; 2020 Dec; 132():110928. PubMed ID: 33128944
[TBL] [Abstract][Full Text] [Related]
13. SIRT3: as simple as it seems?
Lombard DB; Zwaans BM
Gerontology; 2014; 60(1):56-64. PubMed ID: 24192814
[TBL] [Abstract][Full Text] [Related]
14. Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson's disease.
Zhou ZD; Tan EK
Ageing Res Rev; 2020 Sep; 62():101107. PubMed ID: 32535274
[TBL] [Abstract][Full Text] [Related]
15. Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3.
Sol EM; Wagner SA; Weinert BT; Kumar A; Kim HS; Deng CX; Choudhary C
PLoS One; 2012; 7(12):e50545. PubMed ID: 23236377
[TBL] [Abstract][Full Text] [Related]
16. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development.
He J; Shangguan X; Zhou W; Cao Y; Zheng Q; Tu J; Hu G; Liang Z; Jiang C; Deng L; Wang S; Yang W; Zuo Y; Ma J; Cai R; Chen Y; Fan Q; Dong B; Xue W; Tan H; Qi Y; Gu J; Su B; Eugene Chin Y; Chen G; Wang Q; Wang T; Cheng J
Nat Commun; 2021 Jul; 12(1):4371. PubMed ID: 34272364
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin 3 Downregulation in
Smulan LJ; Martinez N; Kiritsy MC; Kativhu C; Cavallo K; Sassetti CM; Singhal A; Remold HG; Kornfeld H
mBio; 2021 Feb; 12(1):. PubMed ID: 33531400
[No Abstract] [Full Text] [Related]
18. Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
Kumar A; Corey C; Scott I; Shiva S; D'Cunha J
PLoS One; 2016; 11(8):e0160783. PubMed ID: 27501149
[TBL] [Abstract][Full Text] [Related]
19. Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart.
Sack MN
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2191-7. PubMed ID: 21984547
[TBL] [Abstract][Full Text] [Related]
20. SIRT3 Deacetylates Ceramide Synthases: IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY.
Novgorodov SA; Riley CL; Keffler JA; Yu J; Kindy MS; Macklin WB; Lombard DB; Gudz TI
J Biol Chem; 2016 Jan; 291(4):1957-1973. PubMed ID: 26620563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
